Business Context and Reporting Period
Company: Investcorp Credit Management BDC, Inc. (ICMB)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2020
Business Overview: ICMB is a closed-end, externally managed business development company (BDC) regulated under the Investment Company Act of 1940. Its primary objective is to maximize total return through current income and capital appreciation by investing in debt and related equity of privately held middle-market companies. The portfolio consists primarily of unitranche, first lien, and second lien loans.
Key Financial Metrics
| Metric | Q3 2020 | Q3 2019 |
|---|---|---|
| Total Assets | $282.2 million | $306.4 million (implied from prior period context) |
| Total Net Assets | $108.5 million | $138.8 million |
| Net Asset Value (NAV) Per Share | $7.81 | $10.19 |
| Market Value Per Share | $3.63 | $6.65 |
| Total Investment Income | $7.0 million | $8.6 million |
| Net Investment Income | $2.7 million | $3.5 million |
| Net Increase in Net Assets from Operations | $2.8 million | $(0.9) million |
| Earnings Per Share (Basic/Diluted) | $0.20 | $(0.07) |
| Total Debt Outstanding | $167.4 million | $175.5 million |
| Asset Coverage Ratio | 1.65x | 1.79x |
| Cash and Restricted Cash | $14.9 million | $10.8 million |
Material Changes vs. Prior Period
- Investment Portfolio: The portfolio fair value decreased from $270.6 million at June 30, 2020, to $261.3 million at September 30, 2020. This reflects sales and repayments of $24.4 million against purchases of $14.2 million.
- Income and Expenses: Total investment income declined by approximately 18% year-over-year, driven by a decrease in the portfolio of income-producing companies. Total expenses decreased by 15% to $4.2 million, primarily due to lower interest expenses (benefiting from lower LIBOR rates) and reduced management fees.
- Unrealized Gains/Losses: The company recorded a net unrealized appreciation of $0.1 million in Q3 2020, a significant improvement from the $4.5 million unrealized depreciation recorded in Q3 2019. This was driven by value increases in Bioplan USA, Inc., Premiere Global Services, Inc., and CB URS Holdings Corporation.
- Debt Reduction: The company repaid $16.0 million on its revolving credit facility, reducing outstanding borrowings from $30.0 million to $14.0 million.
Outlook, Risks, and Management Commentary
- COVID-19 Impact: Management notes that operating results were negatively impacted by the uncertainty surrounding the COVID-19 pandemic, which caused severe disruptions in the global economy and affected the fair value of the investment portfolio. The company continues to monitor portfolio companies' liquidity and operational exposure.
- LIBOR Transition: A significant risk factor is the potential phase-out of LIBOR by the end of 2021. Approximately 99.5% of the debt portfolio bears interest based on floating rates tied to LIBOR. The company may need to renegotiate credit agreements to replace LIBOR with a new standard (e.g., SOFR), which could adversely affect returns.
- Asset Quality: As of September 30, 2020, 67.3% of the portfolio was rated "2" (performing within expectations), while 21.1% was rated "3" (performing below expectations). One loan (1888 Industrial Services, LLC - Term B) was placed on non-accrual status, representing approximately 0.5% of the portfolio.
- Distributions: The board declared a quarterly distribution of $0.15 per share and a supplemental distribution of $0.03 per share for the quarter ended December 31, 2020, payable in January 2021.
- Capital Resources: The company maintains $6.0 million of capacity under its revolving credit facility and intends to generate cash through operations and potential future borrowings.
Key Facts for Investor Verification
- Discount to NAV: The stock trades at a significant discount to its Net Asset Value ($3.63 market price vs. $7.81 NAV), representing a discount of approximately 53%.
- Fee Waivers: The investment adviser waived $112,971 of base management fees for the quarter. Investors should monitor the sustainability of these waivers.
- Unfunded Commitments: The company has $2.6 million in unfunded commitments to three portfolio companies, which could impact future liquidity.
- Debt Maturity: Significant debt obligations, including the $102 million term loan and $14 million revolver, mature on December 5, 2021. The $51.4 million in 2023 Notes mature in July 2023.
- Portfolio Concentration: The largest single investment at fair value is $14.9 million (approximately 5.7% of the portfolio), indicating moderate concentration risk.